Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
The vector of anti-DLL4_VEGF tandem chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human DLL4 and VEGF. The T cells are genetically modified through transduction with a lentiviral vector expressing bivalent scFv of anti-DLL4_VEGF antibody and linked to CD28 and CD3_ signaling domains. And the vector product was designed for the treatment of Breast Cancer.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.